PIONYR IMMUNOTHERAPEUTICS

pionyr-immunotherapeutics-logo

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the bodyโ€™s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics. The companyโ€™s approach, Myeloid Tuningโ„ข, is designed to enhance the immune systemโ€™s anti-tumor response by altering the cellular infiltrate of the tumor microenvironment with high specificity.

#SimilarOrganizations #People #Financial #Website #More

PIONYR IMMUNOTHERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical Therapeutics

Founded:
2015-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.pionyrtx.com

Total Employee:
51+

Status:
Active

Contact:
(415)226-7503

Email Addresses:
[email protected]

Total Funding:
352 M USD

Technology used in webpage:
SPF Amazon AWS Global Accelerator


Similar Organizations

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

gracell-biotechnologies-logo

Gracell Biotechnologies

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

jounce-therapeutics-logo

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

pipeline-therapeutics-logo

Pipeline Therapeutics

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

prelude-therapeutics-logo

Prelude Therapeutics

Prelude Therapeutics is a developer of novel therapies intended to target key drivers of cancer cell growth, survival and resistance.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

rodeo-therapeutics-logo

Rodeo Therapeutics

Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.

stemirna-logo

Stemirna

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

vedanta-biosciences-logo

Vedanta Biosciences

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.


Current Advisors List

leon-chen_image

Leon Chen Board Member @ Pionyr Immunotherapeutics
Board_member

joshua-resnick_image

Joshua Resnick Director @ Pionyr Immunotherapeutics
Board_member
2005-01-01

michael-powell_image

Michael Powell Board Member @ Pionyr Immunotherapeutics
Board_member

carol-gallagher_image

Carol Gallagher Board Member @ Pionyr Immunotherapeutics
Board_member

arjun-goyal_image

Arjun Goyal Board Observer @ Pionyr Immunotherapeutics
Board_observer

Current Employees Featured

venkataraman-sriram_image

Venkataraman Sriram
Venkataraman Sriram VP of ImmunoPharmacology & Early Development @ Pionyr Immunotherapeutics
VP of ImmunoPharmacology & Early Development

leonard-reyno_image

Leonard Reyno
Leonard Reyno Senior Vice President and Chief Medical Officer @ Pionyr Immunotherapeutics
Senior Vice President and Chief Medical Officer

steve-james_image

Steve James
Steve James CEO @ Pionyr Immunotherapeutics
CEO

not_available_image

Sachdev Sidhu
Sachdev Sidhu Founder @ Pionyr Immunotherapeutics
Founder

alicia-levey_image

Alicia Levey
Alicia Levey CBO and SVP @ Pionyr Immunotherapeutics
CBO and SVP

kevin-p-baker_image

Kevin P. Baker
Kevin P. Baker SVP of Preclinical Sciences and Program Management @ Pionyr Immunotherapeutics
SVP of Preclinical Sciences and Program Management

michel-streuli_image

Michel Streuli
Michel Streuli Senior Vice President and Chief Scientific Officer @ Pionyr Immunotherapeutics
Senior Vice President and Chief Scientific Officer

monte-montgomery_image

Monte Montgomery
Monte Montgomery Senior Vice President and Chief Financial Officer @ Pionyr Immunotherapeutics
Senior Vice President and Chief Financial Officer

lisa-stemmerich_image

Lisa Stemmerich
Lisa Stemmerich VP of Human Resources @ Pionyr Immunotherapeutics
VP of Human Resources

not_available_image

Max Krummel
Max Krummel Founder @ Pionyr Immunotherapeutics
Founder

Founder


not_available_image

Max Krummel

not_available_image

Sachdev Sidhu

Investors List

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Corporate Round - Pionyr Immunotherapeutics

janssen-labs_image

JLABS

JLABS investment in Series B - Pionyr Immunotherapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series B - Pionyr Immunotherapeutics

stephen-hoffman-dfdf_image

Stephen Hoffman

Stephen Hoffman investment in Series B - Pionyr Immunotherapeutics

vida-ventures_image

Vida Ventures

Vida Ventures investment in Series B - Pionyr Immunotherapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Pionyr Immunotherapeutics

mission-bay-capital-llc_image

Mission Bay Capital

Mission Bay Capital investment in Series B - Pionyr Immunotherapeutics

california-institute-for-quantitative-biosciences_image

QB3

QB3 investment in Series B - Pionyr Immunotherapeutics

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Series B - Pionyr Immunotherapeutics

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series B - Pionyr Immunotherapeutics

Official Site Inspections

http://www.pionyrtx.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K

  • Host name: ewhserver1302.edgewebhosting.net
  • IP address: 69.63.140.80
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Pionyr Immunotherapeutics" on Search Engine